Table 1.
Cured | Completed treatment | Failure* | Defaulted treatment | Died | Transferred Out† | Total | |
Sex | |||||||
Women | 144 | 90 | 2 | 7 | 17 | 11 | 271 |
Men | 179 | 131 | 3 | 15 | 41 | 15 | 384 |
Birthplace | |||||||
Norway | 119 | 84 | 1 | 5 | 49 | 0 | 258 |
Abroad | 204 | 137 | 4 | 17 | 9 | 26 | 397 |
Age group (yrs) | |||||||
0–14 | 6 | 19 | 0 | 1 | 0 | 0 | 26 |
15–39 | 170 | 105 | 3 | 13 | 4 | 14 | 309 |
40–64 | 59 | 45 | 2 | 4 | 11 | 10 | 131 |
65+ | 88 | 52 | 0 | 4 | 43 | 2 | 189 |
INH-resistance‡ | |||||||
No | 295 | 210 | 0 | 15 | 53 | 22 | 595 |
Yes | 21 | 10 | 5 | 7 | 2 | 4 | 49 |
Mode of detection# (due to symptoms) | |||||||
Yes | 221 | 154 | 3 | 16 | 47 | 12 | 453 |
No | 100 | 67 | 2 | 6 | 11 | 13 | 199 |
Treatment periods | |||||||
1996–1997 | 67 | 48 | 0 | 3 | 19 | 2 | 139 |
1998–1999 | 83 | 58 | 1 | 7 | 20 | 3 | 172 |
2000–2002 | 173 | 115 | 4 | 12 | 19 | 21 | 344 |
*All patients are MDR-TB patients
†All patients have left the country
‡Information for INH susceptibility was available for 98.3% of the patients
#Information for mode of detection was available for 99.5% of the patients